The osteoporosis treatment gap

Journal of Bone and Mineral Research

Volumn 29, Issue 9, 2014, Pages 1926-1928

  Kanis, John A ^a   Svedbom, Axel ^b,c   Harvey, Nicholas ^d,e   McCloskey, Eugene V ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b OptumInsight   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

AUSTRALIA; AUSTRIA; BONE DENSITOMETRY; BONE DENSITY; BULGARIA; DRUG INDUSTRY; ESTONIA; EUROPE; FEMUR FRACTURE; FRAGILITY FRACTURE; FRANCE; HEALTH CARE DISPARITY; HIGH RISK POPULATION; HIP FRACTURE; HORMONE SUBSTITUTION; HOSPITAL DISCHARGE; HUMAN; ITALY; JAW OSTEONECROSIS; LITHUANIA; LOW RISK POPULATION; MEXICO; NOTE; OSTEOPOROSIS; REIMBURSEMENT; RUSSIAN FEDERATION; SPAIN; UNITED KINGDOM; UNITED STATES; COMPLICATION; OSTEOPOROTIC FRACTURES;

BONE DENSITY CONSERVATION AGENTS; HUMANS; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES;

EID: 84906342849     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2301     Document Type: Note

References (28)

1. Hernlund E, Svedbom A, Ivergård M, et al. Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013; 8: 136. DOI: 10.1007/s11657-013-0136-1.
2. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2014. Available from: http://nof.org/files/nof/public/content/file/2791/upload/ 919.pdf.
3. Papaioannou A, Morin S, Cheung AM, et al. Scientific Advisory Council of Osteoporosis Canada. 2010 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010; 182: 1864-73.
4. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA III, Berger M,. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2004; 15: 721-39.
5. Johnell O, Oden A, Caulin F, Kanis JA,. Acute and long term increase in fracture risk after hospitalization for vertebral fracture. Osteoporos Int. 2001; 12: 207-14.
6. Johnell O, Kanis JA, Odén A, et al. Fracture risk following an osteoporotic fracture. Osteoporos Int. 2004; 15: 175-9.
7. Lindsay R, Silverman SL, Cooper C, et al. Risk for new vertebral fracture in the year following a fracture. JAMA. 2001; 285: 320-3.
8. Díez-Pérez A, Hooven FH, Adachi JD, et al. Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW). Bone. 2011; 49: 493-8.
9. Guggina P, Flahive J, Hooven FH, et al. Characteristics associated with anti-osteoporosis medication use: data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort. Bone. 2012; 51: 975-80.
10. Jennings LA, Auerbach AD, Maselli J, Pekow PS, Lindenauer PK, Lee SJ,. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture. J Am Geriatr Soc. 2010; 58: 650-7.
11. Freedman KB, Kaplan FS, Bilker WB, Strom BL, Lowe RA,. Treatment of osteoporosis: are physicians missing an opportunity ? J Bone Joint Surg Am. 2000; 82-A: 1063-70.
12. Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD,. Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum. 2006; 35: 293-305.
13. Nayak S, Roberts MS, Greenspan SL,. Factors associated with diagnosis and treatment of osteoporosis in older adults. Osteoporos Int. 2009; 20: 1963-7.
14. Vaile J, Sullivan L, Bennett C, Bleasel J,. First Fracture Project: addressing the osteoporosis care gap. Intern Med J. 2007; 37: 717-20.
15. Papaioannou A, Giangregorio L, Kvern B, Boulos P, Ioannidis G, Adachi JD,. The osteoporosis care gap in Canada. BMC Musculoskelet Disord. 2004; 5: 11.
16. Bessette L, Ste-Marie LG, Jean S, et al. Recognizing osteoporosis and its consequences in Quebec (ROCQ): background, rationale, and methods of an anti-fracture patient health-management programme. Contemp Clin Trials. 2008; 29: 194-210.
17. Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE,. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int. 2004; 15: 767-78.
18. Haaland DA, Cohen DR, Kennedy CC, Khalidi NA, Adachi JD, Papaioannou A,. Closing the osteoporosis care gap: increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatr. 2009; 9: 28.
19. Swedish National Board of Health and Welfare. Quality and efficiency in Swedish Health Care. Stockholm, Sweden: Swedish Association of Local Authorities and Regions, Swedish National Board of Health and Welfare; 2009.
20. Borgstrom F, Johnell O, Kanis JA, Jonsson B, Rehnberg C,. At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis. Osteoporos Int. 2006; 17: 1459-71.
21. Austin P, Tu J, Ko D, Alter D,. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction. CMAJ. 2008; 179: 901-8.
22. Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD,. Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res. 2014; 29: 1929-1937.
23. Compston J, Cooper A, Cooper C, et al. National Osteoporosis Guideline Group (NOGG). Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK. Maturitas. 2009; 62: 105-8.
24. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster J-Y,. Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2013; 24: 23-57.
25. Lekawasam S, Adachi JD, Agnusdei D, et al. Joint IOF-ECTS GIO Guidelines Working Group. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int. 2012; 23: 2257-76.
26. Wintzell V, Ivergård M, Tankõ LB, et al. PMS105-Resource use related to hip fractures based on data from the ICUROS study. Value Health. 2013; 16 (7): A573-4. DOI: 10.1016/j.jval.2013.08.1548.
27. Svedbom A, Hernlund E,. Ivergård, et al. EU review panel of the IOF. Osteoporosis in the European Union: a compendium of country-specific reports. Arch Osteoporos. 2013; 8: 137.
28. Akesson K, Marsh D, Mitchell PJ, et al. IOF Fracture Working Group. Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int. 2013; 24: 2135-252.